Company Overview and News

 
First Commonwealth CEO to Serve on Community Bank Advisory Board of the Federal Reserve

2018-09-21 globenewswire
INDIANA, Pa., Sept. 21, 2018 (GLOBE NEWSWIRE) -- T. Michael Price, President and CEO of First Commonwealth Financial Corporation, has been selected to serve on the National Community Depository Institutions Advisory Council (CDIAC) for the Federal Reserve Board of Governors in Washington, D.C. Price currently serves on the CDIAC of the Federal Reserve Bank of Cleveland.
FCF

13
No Blood In The Streets: Should You Still Invest In The Tobacco Sector

2018-09-10 seekingalpha - 1
Financial stability and profitability of Altria, Philip Morris International, Imperial Brands, British American Tobacco and Vector Group are critically assessed.
IMBBY PM BUD PE RAI BATS 4162 ITYBF EV VGR AHBIF FCF IMBBF MO

 
FCF / First Commonwealth Financial Corporation FORM 8-K (Current Report)

2018-08-17 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
FCF

 
FCF / First Commonwealth Financial Corporation S-3ASR

2018-08-08 sec.gov
S-3ASR As filed with the Securities and Exchange Commission on August 8, 2018 Registration Statement No. 333-
FCF

 
FCF / First Commonwealth Financial Corporation FORM 10-Q (Quarterly Report)

2018-08-08 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
FCF

 
Is First Commonwealth Financial (FCF) a Great Dividend Play?

2018-08-02 zacks
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.
IBP FCF

 
First Commonwealth CEO Elected to PA Bankers Board of Directors

2018-07-31 globenewswire
INDIANA, Pa., July 31, 2018 (GLOBE NEWSWIRE) -- T. Michael Price, President and CEO of First Commonwealth Financial Corporation, has been elected to the Board of Directors of the Pennsylvania Bankers Association (PA Bankers). Price will serve as the Board’s First Vice Chairman.
FCF

 
Aimia Vs. Air Canada: Who Has The Upper Hand?

2018-07-30 seekingalpha
Air Canada said goodbye to AIMIA more than a year back prompting a 85% selloff in AIMIA shares.
TNTTF ACDVF FCF TD TD GAPFF AC

 
First Commonwealth Financial Corp (FCF) CEO Thomas Price on Q2 2018 Results - Earnings Call Transcript

2018-07-25 seekingalpha
First Commonwealth Financial Corp (NYSE:FCF) Q2 2018 Earnings Conference Call July 25, 2018 2:00 PM ET
FCF

 
First Commonwealth Announces Second Quarter 2018 Earnings; Declares Quarterly Dividend

2018-07-24 globenewswire
INDIANA, Pa., July 24, 2018 (GLOBE NEWSWIRE) -- First Commonwealth Financial Corporation (NYSE:FCF) today announced financial results for the second quarter of 2018.
FCF

2
Broadcom's Buyout Of CA Technologies Looks Like Desperation

2018-07-12 seekingalpha - 1
Broadcom (AVGO) just made international headlines once again. The semiconductor-giant issued a press release after market close yesterday, announcing that it has agreed to buyout CA Technologies (CA) for $18.9 billion. The amount will be funded by cash in hand and $18 billion in fresh debt. The acquisition is certainly going to boost Broadcom’s sales and profitability figures going forward, but the move doesn’t seem like a well-thought out strategic decision.
AVGO FCF

1
Which Valuation Indicator To Use - Let The Data Decide

2018-07-11 seekingalpha
Different indicators give widely differing valuation numbers making it difficult for investors to come to a conclusion.
DCF AAPL TRI PE FCF

 
FCF / First Commonwealth Financial Corporation / VANGUARD GROUP INC - null (Passive Investment)

2018-07-10 sec.gov
firstcommonwealthfinancialco.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
FCF

 
FCF / First Commonwealth Financial Corporation / VANGUARD GROUP INC - null (Passive Investment)

2018-07-10 sec.gov
firstcommonwealthfinancialco.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
FCF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to FCF / First Commonwealth Financial Corporation on message board site Silicon Investor.

FirstCity Liquidating Trust (FCFCL) FirstCity Liquidating Trust (FCFCL) FirstCity Liquidating Trust (FCFCL) FCFS: First Cash, Inc. FCFS: First Cash, Inc. FCFS: First Cash, Inc.
Four Crown Foods Inc. (FCFOF) Four Crown Foods Inc. (FCFOF) Four Crown Foods Inc. (FCFOF) FirstCity (FCFC) FirstCity (FCFC) FirstCity (FCFC)
FCFS First Cash Financial Services FCFS First Cash Financial Services FCFS First Cash Financial Services FCFOF 4CrownFoods.com FCFOF 4CrownFoods.com FCFOF 4CrownFoods.com
FCFN FCFN FCFN
CUSIP: 319829107